Menu
Back to User profile » Dr Hu Liang
Papers published by Dr Hu Liang:
Prognostic Model for the Risk Stratification of Early and Late Recurrence in Hepatitis B Virus-Related Small Hepatocellular Carcinoma Patients with Global Histone Modifications
Duan JL, Nie RC, Xiang ZC, Chen JW, Deng MH, Liang H, Wang FW, Luo RZ, Xie D, Cai MY
Journal of Hepatocellular Carcinoma 2021, 8:493-505
Published Date: 28 May 2021
Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
Lv SH, Li WZ, Liang H, Liu GY, Xia WX, Xiang YQ
Journal of Inflammation Research 2021, 14:2225-2237
Published Date: 25 May 2021
A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma
Li WZ, Hua X, Lv SH, Liang H, Liu GY, Lu N, Bei WX, Xia WX, Xiang YQ
Journal of Inflammation Research 2021, 14:817-828
Published Date: 10 March 2021
Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
Xia WX, Liang H, Lv X, Wang L, Ye YF, Ke LR, Xu LH, Guo X, Xiang YQ
Cancer Management and Research 2019, 11:9813-9827
Published Date: 20 November 2019
The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma
Yu Y, Ke L, Lv X, Ling Y, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y
Cancer Management and Research 2018, 10:1935-1946
Published Date: 9 July 2018